Takahiro Osuga Selected Research

Takahiro Osuga Research Topics

9	Neoplasms (Cancer) 04/2022 - 01/2012
5	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2016
5	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 08/2012
3	Neoplasm Metastasis (Metastasis) 02/2021 - 07/2015
2	Esophageal Neoplasms (Esophageal Cancer) 11/2018 - 10/2015
2	Stomach Neoplasms (Stomach Cancer) 01/2016 - 08/2015
1	Carcinogenesis 04/2022
1	Non-alcoholic Fatty Liver Disease 04/2022
1	Iron Overload 04/2022
1	Cholangiocarcinoma 01/2022
1	Lung Abscess 01/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2021
1	Liposarcoma 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Esophageal Squamous Cell Carcinoma 11/2018
1	Leukemia 06/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2016
1	Fanconi Syndrome (Syndrome, Fanconi) 07/2015
1	Neutropenia 03/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2012
1	Adenocarcinoma 01/2012

5	Liposomes (Liposome)IBA 06/2016 - 01/2012
5	FucoseIBA 06/2016 - 01/2012
4	Pharmaceutical PreparationsIBA 01/2016 - 01/2012
4	FucosyltransferasesIBA 01/2016 - 01/2012
3	Docetaxel (Taxotere)FDA Link 11/2018 - 08/2015
3	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 01/2012
2	gadolinium ethoxybenzyl DTPA FDA Link 04/2022 - 01/2022
2	IronIBA 04/2022 - 11/2021
2	Fluorouracil (Carac)FDA LinkGeneric 11/2018 - 10/2015
2	nedaplatinIBA 11/2018 - 10/2015
2	Bevacizumab (Avastin)FDA Link 07/2015 - 03/2015
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 04/2022
1	CateninsIBA 04/2022
1	8-Hydroxy-2'-DeoxyguanosineIBA 04/2022
1	Ferritins (Ferritin)IBA 04/2022
1	lenvatinibIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	LigandsIBA 09/2021
1	Immune Checkpoint InhibitorsIBA 09/2021
1	eribulin FDA Link 01/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2016
1	sialosyl-Tn antigenIBA 01/2016
1	SialyltransferasesIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Histone Deacetylase InhibitorsIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 08/2015
1	Zoledronic Acid (Zometa)FDA Link 07/2015
1	Denosumab FDA Link 07/2015
1	Capecitabine (Xeloda)FDA Link 03/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 03/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2015
1	Cetuximab (Erbitux)FDA Link 08/2012
1	Tumor Biomarkers (Tumor Markers)IBA 01/2012
1	EnzymesIBA 01/2012
1	AntigensIBA 01/2012
1	CY5.5 cyanine dyeIBA 01/2012